Medical Care

Global Competent Cells Market Research Report 2025

The global market for Competent Cells was valued at US$ 2382 million in the year 2024 and is projected to reach a revised size of US$ 4456 million by 2031, growing at a CAGR of 9.5% during the forecast period.
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
This report aims to provide a comprehensive presentation of the global market for Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent Cells.
The Competent Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Competent Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid Creation
Cre-Lox Recombination (PIR1/PIR2)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Competent Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Competent Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Competent Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Competent Cells Market Perspective (2020-2031)
2.2 Global Competent Cells Growth Trends by Region
2.2.1 Global Competent Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Competent Cells Historic Market Size by Region (2020-2025)
2.2.3 Competent Cells Forecasted Market Size by Region (2026-2031)
2.3 Competent Cells Market Dynamics
2.3.1 Competent Cells Industry Trends
2.3.2 Competent Cells Market Drivers
2.3.3 Competent Cells Market Challenges
2.3.4 Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Competent Cells Players by Revenue
3.1.1 Global Top Competent Cells Players by Revenue (2020-2025)
3.1.2 Global Competent Cells Revenue Market Share by Players (2020-2025)
3.2 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Competent Cells Revenue
3.4 Global Competent Cells Market Concentration Ratio
3.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2024
3.5 Global Key Players of Competent Cells Head office and Area Served
3.6 Global Key Players of Competent Cells, Product and Application
3.7 Global Key Players of Competent Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Competent Cells Breakdown Data by Type
4.1 Global Competent Cells Historic Market Size by Type (2020-2025)
4.2 Global Competent Cells Forecasted Market Size by Type (2026-2031)
5 Competent Cells Breakdown Data by Application
5.1 Global Competent Cells Historic Market Size by Application (2020-2025)
5.2 Global Competent Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Competent Cells Market Size (2020-2031)
6.2 North America Competent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Competent Cells Market Size by Country (2020-2025)
6.4 North America Competent Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Competent Cells Market Size (2020-2031)
7.2 Europe Competent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Competent Cells Market Size by Country (2020-2025)
7.4 Europe Competent Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Competent Cells Market Size (2020-2031)
8.2 Asia-Pacific Competent Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Competent Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Competent Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Competent Cells Market Size (2020-2031)
9.2 Latin America Competent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Competent Cells Market Size by Country (2020-2025)
9.4 Latin America Competent Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Competent Cells Market Size (2020-2031)
10.2 Middle East & Africa Competent Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Competent Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Competent Cells Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Competent Cells Business (2020-2025)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Competent Cells Business (2020-2025)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Competent Cells Introduction
11.4.4 Takara Bio Revenue in Competent Cells Business (2020-2025)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Competent Cells Business (2020-2025)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2020-2025)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Competent Cells Business (2020-2025)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Competent Cells Business (2020-2025)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Competent Cells Business (2020-2025)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2020-2025)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Competent Cells Business (2020-2025)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Competent Cells Introduction
11.12.4 Lucigen Revenue in Competent Cells Business (2020-2025)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Competent Cells Introduction
11.13.4 Zymo Research Revenue in Competent Cells Business (2020-2025)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2020-2025)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Competent Cells Introduction
11.15.4 Bioline Revenue in Competent Cells Business (2020-2025)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Competent Cells Business (2020-2025)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Competent Cells Business (2020-2025)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Competent Cells Introduction
11.18.4 Cell Applications Revenue in Competent Cells Business (2020-2025)
11.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Competent Cells Business (2020-2025)
11.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Competent Cells Business (2020-2025)
11.20.5 Scarab Genomics Recent Development
11.21 GCC Biotech
11.21.1 GCC Biotech Company Details
11.21.2 GCC Biotech Business Overview
11.21.3 GCC Biotech Competent Cells Introduction
11.21.4 GCC Biotech Revenue in Competent Cells Business (2020-2025)
11.21.5 GCC Biotech Recent Development
11.22 SMOBIO Technology
11.22.1 SMOBIO Technology Company Details
11.22.2 SMOBIO Technology Business Overview
11.22.3 SMOBIO Technology Competent Cells Introduction
11.22.4 SMOBIO Technology Revenue in Competent Cells Business (2020-2025)
11.22.5 SMOBIO Technology Recent Development
11.23 Edge BioSystems
11.23.1 Edge BioSystems Company Details
11.23.2 Edge BioSystems Business Overview
11.23.3 Edge BioSystems Competent Cells Introduction
11.23.4 Edge BioSystems Revenue in Competent Cells Business (2020-2025)
11.23.5 Edge BioSystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemically Competent Cells
Table 3. Key Players of Electrocompetent Cells
Table 4. Global Competent Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Competent Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Competent Cells Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Competent Cells Market Share by Region (2020-2025)
Table 8. Global Competent Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Competent Cells Market Share by Region (2026-2031)
Table 10. Competent Cells Market Trends
Table 11. Competent Cells Market Drivers
Table 12. Competent Cells Market Challenges
Table 13. Competent Cells Market Restraints
Table 14. Global Competent Cells Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Competent Cells Market Share by Players (2020-2025)
Table 16. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
Table 17. Ranking of Global Top Competent Cells Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Competent Cells, Headquarters and Area Served
Table 20. Global Key Players of Competent Cells, Product and Application
Table 21. Global Key Players of Competent Cells, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Competent Cells Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Competent Cells Revenue Market Share by Type (2020-2025)
Table 25. Global Competent Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Competent Cells Revenue Market Share by Type (2026-2031)
Table 27. Global Competent Cells Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Competent Cells Revenue Market Share by Application (2020-2025)
Table 29. Global Competent Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Competent Cells Revenue Market Share by Application (2026-2031)
Table 31. North America Competent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Competent Cells Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Competent Cells Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Competent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Competent Cells Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Competent Cells Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Competent Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Competent Cells Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Competent Cells Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Competent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Competent Cells Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Competent Cells Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Competent Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Competent Cells Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Competent Cells Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck KGaA Company Details
Table 47. Merck KGaA Business Overview
Table 48. Merck KGaA Competent Cells Product
Table 49. Merck KGaA Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 50. Merck KGaA Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Competent Cells Product
Table 54. Thermo Fisher Scientific Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Agilent Technologies Company Details
Table 57. Agilent Technologies Business Overview
Table 58. Agilent Technologies Competent Cells Product
Table 59. Agilent Technologies Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 60. Agilent Technologies Recent Development
Table 61. Takara Bio Company Details
Table 62. Takara Bio Business Overview
Table 63. Takara Bio Competent Cells Product
Table 64. Takara Bio Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 65. Takara Bio Recent Development
Table 66. Promega Corporation Company Details
Table 67. Promega Corporation Business Overview
Table 68. Promega Corporation Competent Cells Product
Table 69. Promega Corporation Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 70. Promega Corporation Recent Development
Table 71. Beijing TransGen Biotech Company Details
Table 72. Beijing TransGen Biotech Business Overview
Table 73. Beijing TransGen Biotech Competent Cells Product
Table 74. Beijing TransGen Biotech Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 75. Beijing TransGen Biotech Recent Development
Table 76. GeneScript Corporation Company Details
Table 77. GeneScript Corporation Business Overview
Table 78. GeneScript Corporation Competent Cells Product
Table 79. GeneScript Corporation Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 80. GeneScript Corporation Recent Development
Table 81. Yeastern Biotech Company Details
Table 82. Yeastern Biotech Business Overview
Table 83. Yeastern Biotech Competent Cells Product
Table 84. Yeastern Biotech Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 85. Yeastern Biotech Recent Development
Table 86. New England Biolabs Company Details
Table 87. New England Biolabs Business Overview
Table 88. New England Biolabs Competent Cells Product
Table 89. New England Biolabs Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 90. New England Biolabs Recent Development
Table 91. QIAGEN N.V. Company Details
Table 92. QIAGEN N.V. Business Overview
Table 93. QIAGEN N.V. Competent Cells Product
Table 94. QIAGEN N.V. Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 95. QIAGEN N.V. Recent Development
Table 96. OriGene Technologies Company Details
Table 97. OriGene Technologies Business Overview
Table 98. OriGene Technologies Competent Cells Product
Table 99. OriGene Technologies Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 100. OriGene Technologies Recent Development
Table 101. Lucigen Company Details
Table 102. Lucigen Business Overview
Table 103. Lucigen Competent Cells Product
Table 104. Lucigen Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 105. Lucigen Recent Development
Table 106. Zymo Research Company Details
Table 107. Zymo Research Business Overview
Table 108. Zymo Research Competent Cells Product
Table 109. Zymo Research Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 110. Zymo Research Recent Development
Table 111. Bio-Rad Laboratories Company Details
Table 112. Bio-Rad Laboratories Business Overview
Table 113. Bio-Rad Laboratories Competent Cells Product
Table 114. Bio-Rad Laboratories Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 115. Bio-Rad Laboratories Recent Development
Table 116. Bioline Company Details
Table 117. Bioline Business Overview
Table 118. Bioline Competent Cells Product
Table 119. Bioline Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 120. Bioline Recent Development
Table 121. Delphi Genetics Company Details
Table 122. Delphi Genetics Business Overview
Table 123. Delphi Genetics Competent Cells Product
Table 124. Delphi Genetics Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 125. Delphi Genetics Recent Development
Table 126. IBA GmBH Company Details
Table 127. IBA GmBH Business Overview
Table 128. IBA GmBH Competent Cells Product
Table 129. IBA GmBH Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 130. IBA GmBH Recent Development
Table 131. Cell Applications Company Details
Table 132. Cell Applications Business Overview
Table 133. Cell Applications Competent Cells Product
Table 134. Cell Applications Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 135. Cell Applications Recent Development
Table 136. BioDynamics Laboratory Company Details
Table 137. BioDynamics Laboratory Business Overview
Table 138. BioDynamics Laboratory Competent Cells Product
Table 139. BioDynamics Laboratory Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 140. BioDynamics Laboratory Recent Development
Table 141. Scarab Genomics Company Details
Table 142. Scarab Genomics Business Overview
Table 143. Scarab Genomics Competent Cells Product
Table 144. Scarab Genomics Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 145. Scarab Genomics Recent Development
Table 146. GCC Biotech Company Details
Table 147. GCC Biotech Business Overview
Table 148. GCC Biotech Competent Cells Product
Table 149. GCC Biotech Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 150. GCC Biotech Recent Development
Table 151. SMOBIO Technology Company Details
Table 152. SMOBIO Technology Business Overview
Table 153. SMOBIO Technology Competent Cells Product
Table 154. SMOBIO Technology Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 155. SMOBIO Technology Recent Development
Table 156. Edge BioSystems Company Details
Table 157. Edge BioSystems Business Overview
Table 158. Edge BioSystems Competent Cells Product
Table 159. Edge BioSystems Revenue in Competent Cells Business (2020-2025) & (US$ Million)
Table 160. Edge BioSystems Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report


List of Figures
Figure 1. Competent Cells Picture
Figure 2. Global Competent Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Competent Cells Market Share by Type: 2024 VS 2031
Figure 4. Chemically Competent Cells Features
Figure 5. Electrocompetent Cells Features
Figure 6. Global Competent Cells Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Competent Cells Market Share by Application: 2024 VS 2031
Figure 8. Subcloning & Routine Cloning Case Studies
Figure 9. Phage Display Library Construction Case Studies
Figure 10. Toxic/Unstable DNA Cloning Case Studies
Figure 11. High-Throughput Cloning Case Studies
Figure 12. Protein Expression Case Studies
Figure 13. Mutagenesis Case Studies
Figure 14. Single-Stranded DNA Production Case Studies
Figure 15. Bacmid Creation Case Studies
Figure 16. Cre-Lox Recombination (PIR1/PIR2) Case Studies
Figure 17. Competent Cells Report Years Considered
Figure 18. Global Competent Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Competent Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Competent Cells Market Share by Region: 2024 VS 2031
Figure 21. Global Competent Cells Market Share by Players in 2024
Figure 22. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2024
Figure 24. North America Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Competent Cells Market Share by Country (2020-2031)
Figure 26. United States Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Competent Cells Market Share by Country (2020-2031)
Figure 30. Germany Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Competent Cells Market Share by Region (2020-2031)
Figure 38. China Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Competent Cells Market Share by Country (2020-2031)
Figure 46. Mexico Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Competent Cells Market Share by Country (2020-2031)
Figure 50. Turkey Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Competent Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Merck KGaA Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 55. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 56. Takara Bio Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 57. Promega Corporation Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 58. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 59. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 60. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 61. New England Biolabs Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 62. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 63. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 64. Lucigen Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 65. Zymo Research Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 66. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 67. Bioline Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 68. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 69. IBA GmBH Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 70. Cell Applications Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 71. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 72. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 73. GCC Biotech Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 74. SMOBIO Technology Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 75. Edge BioSystems Revenue Growth Rate in Competent Cells Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies